BAVARIAN NOR NAM. DK 10BAVARIAN NOR NAM. DK 10BAVARIAN NOR NAM. DK 10

BAVARIAN NOR NAM. DK 10

No trades
See on Supercharts
Market capitalization
‪1.53 B‬EUR
‪197.84 M‬EUR
‪946.46 M‬EUR
‪77.68 M‬
Beta (1Y)
0.95

About BAVARIAN NOR NAM. DK 10

CEO
Paul Chaplin
Headquarters
Hellerup
Employees (FY)
‪1.38 K‬
Founded
1992
ISIN
DK0015998017
FIGI
BBG000D6P272
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BAVARIAN NOR NAM. DK 10 stocks are traded under the ticker BV3.
BAVARIAN NOR NAM. DK 10 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BAVARIAN NOR NAM. DK 10 has a max estimate of 46.20 EUR and a min estimate of 22.76 EUR.
BV3 earnings for the last quarter are −0.59 EUR per share, whereas the estimation was 0.78 EUR resulting in a −175.00% surprise. The estimated earnings for the next quarter are 1.22 EUR per share. See more details about BAVARIAN NOR NAM. DK 10 earnings.
BAVARIAN NOR NAM. DK 10 revenue for the last quarter amounts to ‪184.11 M‬ EUR despite the estimated figure of ‪237.60 M‬ EUR. In the next quarter revenue is expected to reach ‪316.29 M‬ EUR.
Yes, you can track BAVARIAN NOR NAM. DK 10 financials in yearly and quarterly reports right on TradingView.
BV3 net income for the last quarter is ‪120.89 M‬ EUR, while the quarter before that showed ‪−45.57 M‬ EUR of net income which accounts for 365.30% change. Track more BAVARIAN NOR NAM. DK 10 financial stats to get the full picture.
No, BV3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BV3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAVARIAN NOR NAM. DK 10 stock right from TradingView charts — choose your broker and connect to your account.
BV3 reached its all-time high on Aug 4, 2022 with the price of 56.20 EUR, and its all-time low was 3.10 EUR and was reached on Oct 2, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.38 K‬ employees. See our rating of the largest employees — is BAVARIAN NOR NAM. DK 10 on this list?
We've gathered analysts' opinions on BAVARIAN NOR NAM. DK 10 future price: according to them, BV3 price has a max estimate of 46.20 EUR and a min estimate of 22.76 EUR. Read a more detailed BAVARIAN NOR NAM. DK 10 forecast: see what analysts think of BAVARIAN NOR NAM. DK 10 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAVARIAN NOR NAM. DK 10 EBITDA is ‪275.11 M‬ EUR, and current EBITDA margin is 29.07%. See more stats in BAVARIAN NOR NAM. DK 10 financial statements.